Loading organizations...
§ Private Profile · Boston, MA, USA
Biotechnology company cultivating sustainable plant cell-derived bioactive ingredients for consumer product manufacturers in nutrition and wellness.
Based in Boston, Massachusetts, Ayana Bio is a biotechnology company that uses proprietary plant and fungal cell culture technology to produce sustainable bioactive ingredients for the global health and wellness sector. The business cultivates high-purity ingredients such as saffron, ginger, echinacea, and lemon balm directly from cells rather than harvesting whole plants, supplying standardized nutritional components to consumer packaged goods manufacturers. Operating as an ingredient supplier with fewer than 500 employees, the enterprise launched with $30 million in Series A funding to scale its commercial laboratory operations. Ayana Bio is backed by prominent institutional investors including Viking Global Investors and Cascade Investment, and maintains strategic development partnerships with Ginkgo Bioworks and South Korean beverage manufacturer Woongjin Foods. The organization was founded in 2021 by Effendi Leonard and Hasan Celik as a venture originating from the Ferment consortium.
Ayana Bio has raised $30.0M across 1 funding round.
Ayana Bio has raised $30.0M in total across 1 funding round.
Ayana Bio has raised $30.0M in total across 1 funding round.
Ayana Bio's investors include Cascade Investment, Viking Global Investors.
Ayana Bio has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series A in September 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 9, 2021 | $30M Series A | Cascade Investment, Viking Global Investors | — | Announced |